МЕТАБОЛІЧНІ ІНГІБІТОРИ ТА ЇХ ВПЛИВ НА МІГРАЦІЮ, ІНВАЗІЮ ТА МЕТАСТАЗУВАННЯ РАКОВИХ КЛІТИН

• Date: 2026
• Author Affiliations: Y. Stepanov — R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv, Ukraine; Y. Yakshibaeva — R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv, Ukraine; V. Semenkova — Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; L. Stepanova — Institute of Biology and Medicine, Taras Shevchenko National University of Kyiv, Kyiv, Ukraine; G. Solyanik — R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the National Academy of Sciences of Ukraine, Kyiv, Ukraine
• Keywords: keywords
• Main Authors: Stepanov, Y., Yakshibaeva, Y., Semenkova, V., Stepanova, L., Solyanik, G.
• Format: Article
• Language: English
• Published: PH Akademperiodyka 2026
• Subjects: інгібітори гліколізу; інгібітори окисного фосфорилювання; міграція; інвазія; метастазування
• Online Access: https://exp-oncology.com.ua/index.php/Exp/article/view/613
• Journal Title: Experimental Oncology

Cancer metastasis, the process by which cancer cells spread from the primary tumor to distant sites, remains the leading cause of cancer-related deaths. Th s complex process involves a series of steps, including cell detachment, migration, invasion, survival in the circulatory system, extravasation,...